We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. markets closed

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
2.9100-0.0300 (-1.02%)
At close: 04:00PM EDT
2.8700 -0.04 (-1.37%)
After hours: 05:57PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Performance Outlook
Previous Close2.9400
Open2.9200
Bid2.8900 x 500
Ask2.9200 x 300
Day's Range2.8600 - 3.0700
52 Week Range0.5000 - 3.2200
Volume2,131,427
Avg. Volume2,639,611
Market Cap437.457M
Beta (5Y Monthly)1.71
PE Ratio (TTM)N/A
EPS (TTM)-0.8000
Earnings DateMay 09, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for HRTX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Heron Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 11/20/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    5 months agoArgus Research
View more